FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912245247> ?p ?o ?g. }

• W2912245247 endingPage "1485" @default.
• W2912245247 startingPage "1479" @default.
• W2912245247 abstract "Abstract Purpose: Pazopanib is active in soft-tissue sarcoma (STS). Because pazopanib absorption is pH-dependent, coadministration with gastric acid–suppressive (GAS) agents such as proton pump inhibitors could affect exposure of pazopanib, and thereby its therapeutic effects. Patients and Methods: The EORTC 62043 and 62072 were single-arm phase II and placebo-controlled phase III studies, respectively, of pazopanib in advanced STS. We first compared the outcome of patients treated with pazopanib with or without GAS agents for ≥80% of treatment duration, and subsequently using various thresholds. The impact of concomitant GAS therapy was assessed on progression-free survival (PFS) and overall survival (OS) using multivariate Cox models, exploring and comparing also the potential effect on placebo-treated patients. Results: Of 333 eligible patients, 59 (17.7%) received concomitant GAS therapy for &gt;80% of pazopanib treatment duration. Median PFS was shorter in GAS therapy users versus nonusers: 2.8 vs. 4.6 months, respectively [HR, 1.49; 95% confidence interval (CI), 1.11–1.99; P = 0.01]. Concomitant administration of GAS therapy was also associated with a shorter median OS: 8.0 vs. 12.6 months (HR, 1.81; 95% CI, 1.31–2.49; P &lt; 0.01). The longer the overlapping use of GAS agents and pazopanib, the worse the outcome with pazopanib. These effects were not observed in placebo-treated patients (HR, 0.82; 95% CI, 0.51–1.34; P = 0.43 for PFS and HR, 0.84; 95% CI, 0.48–1.48; P = 0.54 for OS). Conclusions: Coadministration of long-term GAS therapy with pazopanib was associated with significantly shortened PFS and OS. Withdrawal of GAS agents must be considered whenever possible. Therapeutic drug monitoring of pazopanib plasma concentrations may be helpful for patients on pazopanib and GAS therapy." @default.
• W2912245247 created "2019-02-21" @default.
• W2912245247 creator A5001102421 @default.
• W2912245247 creator A5013591523 @default.
• W2912245247 creator A5020899956 @default.
• W2912245247 creator A5025935523 @default.
• W2912245247 creator A5038603211 @default.
• W2912245247 creator A5039048580 @default.
• W2912245247 creator A5040551223 @default.
• W2912245247 creator A5042679338 @default.
• W2912245247 creator A5043717798 @default.
• W2912245247 creator A5047837719 @default.
• W2912245247 creator A5066380305 @default.
• W2912245247 creator A5074174053 @default.
• W2912245247 creator A5076690638 @default.
• W2912245247 creator A5091114658 @default.
• W2912245247 date "2019-03-01" @default.
• W2912245247 modified "2023-10-15" @default.
• W2912245247 title "Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials" @default.
• W2912245247 cites W1976487307 @default.
• W2912245247 cites W2002795751 @default.
• W2912245247 cites W2028711963 @default.
• W2912245247 cites W2052683946 @default.
• W2912245247 cites W2061817827 @default.
• W2912245247 cites W2079272324 @default.
• W2912245247 cites W2100116917 @default.
• W2912245247 cites W2101776780 @default.
• W2912245247 cites W2107230638 @default.
• W2912245247 cites W2109308320 @default.
• W2912245247 cites W2143555751 @default.
• W2912245247 cites W2238807295 @default.
• W2912245247 cites W2267994443 @default.
• W2912245247 cites W2313856189 @default.
• W2912245247 cites W2326174046 @default.
• W2912245247 cites W2500897030 @default.
• W2912245247 cites W2530532085 @default.
• W2912245247 cites W2574575220 @default.
• W2912245247 cites W2765105604 @default.
• W2912245247 cites W2765595053 @default.
• W2912245247 cites W4237679152 @default.
• W2912245247 doi "https://doi.org/10.1158/1078-0432.ccr-18-2748" @default.
• W2912245247 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30765389" @default.
• W2912245247 hasPublicationYear "2019" @default.
• W2912245247 type Work @default.
• W2912245247 sameAs 2912245247 @default.
• W2912245247 citedByCount "54" @default.
• W2912245247 countsByYear W29122452472019 @default.
• W2912245247 countsByYear W29122452472020 @default.
• W2912245247 countsByYear W29122452472021 @default.
• W2912245247 countsByYear W29122452472022 @default.
• W2912245247 countsByYear W29122452472023 @default.
• W2912245247 crossrefType "journal-article" @default.
• W2912245247 hasAuthorship W2912245247A5001102421 @default.
• W2912245247 hasAuthorship W2912245247A5013591523 @default.
• W2912245247 hasAuthorship W2912245247A5020899956 @default.
• W2912245247 hasAuthorship W2912245247A5025935523 @default.
• W2912245247 hasAuthorship W2912245247A5038603211 @default.
• W2912245247 hasAuthorship W2912245247A5039048580 @default.
• W2912245247 hasAuthorship W2912245247A5040551223 @default.
• W2912245247 hasAuthorship W2912245247A5042679338 @default.
• W2912245247 hasAuthorship W2912245247A5043717798 @default.
• W2912245247 hasAuthorship W2912245247A5047837719 @default.
• W2912245247 hasAuthorship W2912245247A5066380305 @default.
• W2912245247 hasAuthorship W2912245247A5074174053 @default.
• W2912245247 hasAuthorship W2912245247A5076690638 @default.
• W2912245247 hasAuthorship W2912245247A5091114658 @default.
• W2912245247 hasBestOaLocation W29122452471 @default.
• W2912245247 hasConcept C121608353 @default.
• W2912245247 hasConcept C126322002 @default.
• W2912245247 hasConcept C126894567 @default.
• W2912245247 hasConcept C142724271 @default.
• W2912245247 hasConcept C143998085 @default.
• W2912245247 hasConcept C168563851 @default.
• W2912245247 hasConcept C204243189 @default.
• W2912245247 hasConcept C204787440 @default.
• W2912245247 hasConcept C27081682 @default.
• W2912245247 hasConcept C2778256501 @default.
• W2912245247 hasConcept C2778439243 @default.
• W2912245247 hasConcept C2778629024 @default.
• W2912245247 hasConcept C2779384505 @default.
• W2912245247 hasConcept C2779490328 @default.
• W2912245247 hasConcept C44249647 @default.
• W2912245247 hasConcept C71924100 @default.
• W2912245247 hasConcept C90924648 @default.
• W2912245247 hasConcept C98274493 @default.
• W2912245247 hasConceptScore W2912245247C121608353 @default.
• W2912245247 hasConceptScore W2912245247C126322002 @default.
• W2912245247 hasConceptScore W2912245247C126894567 @default.
• W2912245247 hasConceptScore W2912245247C142724271 @default.
• W2912245247 hasConceptScore W2912245247C143998085 @default.
• W2912245247 hasConceptScore W2912245247C168563851 @default.
• W2912245247 hasConceptScore W2912245247C204243189 @default.
• W2912245247 hasConceptScore W2912245247C204787440 @default.
• W2912245247 hasConceptScore W2912245247C27081682 @default.
• W2912245247 hasConceptScore W2912245247C2778256501 @default.
• W2912245247 hasConceptScore W2912245247C2778439243 @default.
• W2912245247 hasConceptScore W2912245247C2778629024 @default.
• W2912245247 hasConceptScore W2912245247C2779384505 @default.

• next